Portfolio (Quarterly)
Guide ↗
China Universal Asset Management Co., Ltd.
· CIK 0001906594| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 27,568.0 | $736K | 0.06% | -2K | -6.8% | $26.71 | -21.0% |
| 62 | — | INDIVIOR PLC | — | 20,345.0 | $730K | 0.06% | -2K | -7.0% | $35.88 | — |
| 63 | IMVT | IMMUNOVANT INC | Healthcare | 28,561.0 | $726K | 0.06% | -2K | -6.5% | $25.42 | +34.3% |
| 64 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 15,463.0 | $720K | 0.06% | -1K | -6.3% | $46.55 | -20.9% |
| 65 | FOLD | AMICUS THERAPEUTICS INC | Healthcare | 50,275.0 | $716K | 0.06% | -4K | -7.0% | $14.24 | +1.8% |
| 66 | ADMA | ADMA BIOLOGICS INC | Healthcare | 38,782.0 | $707K | 0.05% | -3K | -7.3% | $18.24 | -54.8% |
| 67 | ELV | ELEVANCE HEALTH INC | Healthcare | 2,000.0 | $701K | 0.05% | -1K | -33.3% | $350.55 | +12.6% |
| 68 | ALAB | ASTERA LABS INC | Technology | 4,200.0 | $699K | 0.05% | -6K | -58.8% | $166.36 | +84.5% |
| 69 | GRAL | GRAIL INC | Healthcare | 7,952.0 | $681K | 0.05% | -867.0 | -9.8% | $85.59 | -21.5% |
| 70 | WVE | WAVE LIFE SCIENCES LTD | Healthcare | 39,742.0 | $676K | 0.05% | -38K | -49.0% | $17.00 | -62.5% |
| 71 | MNDY | MONDAY.COM LTD | Technology | 4,500.0 | $664K | 0.05% | -1K | -18.2% | $147.56 | -46.4% |
| 72 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 8,375.0 | $662K | 0.05% | -431.0 | -4.9% | $78.99 | +24.9% |
| 73 | AMRX | AMNEAL PHARMACEUTICALS INC | Healthcare | 51,225.0 | $645K | 0.05% | -4K | -7.0% | $12.60 | -1.4% |
| 74 | RMBS | RAMBUS INC | Technology | 7,000.0 | $643K | 0.05% | -1K | -12.5% | $91.89 | +55.6% |
| 75 | ACLX | ARCELLX INC | Healthcare | 9,422.0 | $614K | 0.05% | -299.0 | -3.1% | $65.20 | +76.5% |
| 76 | SUPN | SUPERNUS PHARMACEUTICALS INC | Healthcare | 12,343.0 | $613K | 0.05% | -1K | -8.1% | $49.70 | -3.0% |
| 77 | LGND | LIGAND PHARMACEUTICALS | Healthcare | 3,207.0 | $606K | 0.05% | -228.0 | -6.6% | $189.07 | +21.3% |
| 78 | TERN | TERNS PHARMACEUTICALS INC | Healthcare | 14,878.0 | $601K | 0.05% | -461.0 | -3.0% | $40.40 | +31.1% |
| 79 | RGEN | REPLIGEN CORP | Healthcare | 3,600.0 | $590K | 0.04% | -1K | -28.0% | $163.86 | -29.8% |
| 80 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 19,960.0 | $580K | 0.04% | -1K | -5.0% | $29.04 | -28.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
39.5%
Healthcare
21.2%
Communication Services
12.4%
Financial Services
10.6%
Consumer Cyclical
10.1%
Consumer Defensive
2.7%
Industrials
1.9%
Utilities
0.6%
Basic Materials
0.5%
Energy
0.4%